These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 3729345)
1. Pharmacokinetics of cefotaxime, moxalactam, and cefoperazone in the early puerperium. Charles D; Larsen B Antimicrob Agents Chemother; 1986 May; 29(5):873-6. PubMed ID: 3729345 [TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacokinetics of four new cephalosporins: moxalactam, cefotaxime, cefoperazone and ceftazidime in neonates. Bégué P; Safran C; Quiniou F; Lasfargues G; Quinet B Dev Pharmacol Ther; 1984; 7 Suppl 1():105-8. PubMed ID: 6097425 [No Abstract] [Full Text] [Related]
3. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers. Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967 [TBL] [Abstract][Full Text] [Related]
4. Assessment of serum bactericidal activity after administration of cefoperazone, cefotaxime, ceftizoxime, and moxalactam to healthy subjects. Barriere SL; Ozasa DC; Mordenti J Antimicrob Agents Chemother; 1985 Jul; 28(1):55-7. PubMed ID: 3929680 [TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam. Kemmerich B; Lode H; Belmega G; Jendroschek T; Borner K; Koeppe P Antimicrob Agents Chemother; 1983 Mar; 23(3):429-34. PubMed ID: 6303213 [TBL] [Abstract][Full Text] [Related]
6. The serum bactericidal activity of latamoxef (moxalactam), cefoperazone and cefotaxime. McNamee W; Drusano GL; Tatem BA; Standiford HC J Antimicrob Chemother; 1984 Nov; 14(5):491-7. PubMed ID: 6096348 [TBL] [Abstract][Full Text] [Related]
7. Correlation of predicted serum bactericidal activities and values measured in volunteers. Drusano G; Standiford H; Ryan P; McNamee W; Tatem B; Schimpff S Eur J Clin Microbiol; 1986 Feb; 5(1):88-92. PubMed ID: 3084247 [TBL] [Abstract][Full Text] [Related]
8. In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains. Baker CN; Thornsberry C; Jones RN Antimicrob Agents Chemother; 1980 Apr; 17(4):757-61. PubMed ID: 6249195 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis. Schaad UB; McCracken GH; Loock CA; Thomas ML J Infect Dis; 1981 Feb; 143(2):156-63. PubMed ID: 6260870 [TBL] [Abstract][Full Text] [Related]
11. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa. Corrado ML; Landesman SH; Cherubin CE Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178 [TBL] [Abstract][Full Text] [Related]
12. Penetration and clearance of cefoperazone and moxalactam in pleural fluid. Yamada H; Iwanaga T; Nakanishi H; Yamaguchi M; Iida K Antimicrob Agents Chemother; 1985 Jan; 27(1):93-5. PubMed ID: 3985598 [TBL] [Abstract][Full Text] [Related]
13. A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime. Wise R; Andrews JM Eur J Clin Microbiol; 1983 Oct; 2(5):505-8. PubMed ID: 6315427 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis. McCracken GH; Nelson JD; Grimm L Antimicrob Agents Chemother; 1982 Feb; 21(2):262-7. PubMed ID: 6280599 [TBL] [Abstract][Full Text] [Related]
15. Differences among moxalactam, cefoperazone, and cefotaxime in activity against multiple-antibiotic-resistant gram-negative bacteria. Preston DA Rev Infect Dis; 1982; 4 Suppl():S516-21. PubMed ID: 6296965 [TBL] [Abstract][Full Text] [Related]
16. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli. Lang SD; Edwards DJ; Durack DT Antimicrob Agents Chemother; 1980 Mar; 17(3):488-93. PubMed ID: 6252831 [TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone. Greenfield RA; Kurzynski TA; Craig WA Antimicrob Agents Chemother; 1982 May; 21(5):846-7. PubMed ID: 6285817 [TBL] [Abstract][Full Text] [Related]
18. Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens. Miller MA; LeFrock JL; Vercler MJ Microbiol Immunol; 1981; 25(11):1119-27. PubMed ID: 6276701 [TBL] [Abstract][Full Text] [Related]
19. The effects of latamoxef, cefotaxime, and cefoperazone on platelet function and coagulation in normal volunteers. Weitekamp MR; Caputo GM; Al-Mondhiry HA; Aber RC J Antimicrob Chemother; 1985 Jul; 16(1):95-101. PubMed ID: 4044467 [TBL] [Abstract][Full Text] [Related]
20. Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa. Mintz L; Drew WL Antimicrob Agents Chemother; 1981 Feb; 19(2):332-4. PubMed ID: 6289731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]